Current Medical Research and Opinion

(ISSN: 0300-7995, 1473-4877)

2009 - 25 (10)

  • Efficacy and safety of the dipeptidyl peptidase-4 inhibitor alogliptin added to pioglitazone in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled study. 
 
 
 
Medscape    MedscapeCME    eMedicine    Drugs    MEDLINE    All
All material on this website is protected by copyright, Copyright © 1994-2009 by Medscape. This website also contains material copyrighted by 3rd parties.